Watch Ticker

Olema Pharmaceuticals, Inc. Common Stock

Go to Olema Pharmaceuticals, Inc. Common Stock Website

$5.04

-0.33 (-6.24%)

Live

Previous Close

$5.37

Day Range

$4.9846 - $5.36

Previous Day Range

$5.27 - $5.66

Market Cap

$370.2 million USD

Day Vol.

284166

Previous Day Vol.

772124

Currency

USD

Primary Exchange

Nasdaq

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcom...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Olema Oncology Announces Palazestrant Dose Selection and Trial-in-Progress Poster at ASCO 2025 Annual Meeting

Olema Oncology announced the selection of a 90 mg once-daily dose of palazestrant for its Phase 3 OPERA-01 monotherapy trial and OPERA-02 combination trial with ribociclib. The company will present a trial-in-progress poster for OPERA-01 at the ASCO 2025 Annual Meeting.

Related tickers: OLMA.

Read Full Article

Delveinsight - Metastatic HR+/HER2- Breast Cancer Market—The Road Ahead for Targeted Therapies and Personalized Medicine | DelveInsight

The metastatic HR+/HER2- breast cancer market is expected to grow due to the launch of several novel emerging therapies, which are anticipated to change the treatment landscape and improve survival outcomes for this patient population.

Related tickers: PFE, NVS, ARVN, OLMA, RHHBY, LLY.

Read Full Article

Trending Tickers

Please sign in to view